Home » Topics » BioWorld Science

BioWorld Science
RSS

Better late than never for schizophrenia gene targeting

Oct. 14, 2019

[177Lu]PSMA-R2 shows strong antitumor activity in prostate cancer xenograft model

Oct. 14, 2019

Well Marker Bio describes new macrophage-stimulating protein receptor inhibitors

Oct. 14, 2019

Emory University discloses CXCR-4 and/or CCR5 antagonists

Oct. 14, 2019

New insulin receptor partial agonists discovered at Merck & Co.

Oct. 14, 2019

ABCC3 as a novel pharmacological target in pancreatic cancer

Oct. 14, 2019

Novartis presents data from ASCEND-7 phase II study of ceritinib

Oct. 14, 2019

Phase II RESIST study of MAP-4343 begins in patients with drug-resistant depression

Oct. 14, 2019

Libella Gene Therapeutics initiates phase I study of its AAV-hTERT gene therapy

Oct. 14, 2019

Enrollment begins in first-in-human study of REGN-5459

Oct. 14, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...